Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5. No direct content changes to the study page are shown.
    Difference
    0.1%
    Check dated 2026-06-05T20:47:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new site revision label (v3.5.4) has been added, replacing the previous revision (v3.5.3). This indicates a platform update rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T14:26:21.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows an updated site revision identifier (moving from v3.5.2 to v3.5.3), indicating a platform/version update without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:43.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:09.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:49.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.